Concepedia

Eva Hambruch

EH

Statistics

Publications

11

Citations

704

H-Index

11

Active since

2005

Affiliations

Phenex Pharmaceuticals (Germany)(Current)

Synovo (Germany)

Ruhr University Bochum

Technical University of Munich

Helmholtz Zentrum München

Eva Hambruch is an author at Phenex Pharmaceuticals (Germany) specializing in molecular pharmacology, pharmacology, and molecular biology.

Publications per year

2005–2022

11

Publications

11

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction

Philipp Schwabl, Eva Hambruch, Berit Seeland et al. · Journal of Hepatology · 2016 · 171 citations · Full text

, , +16

Membrane Association of the Cycling Peroxisome Import Receptor Pex5p

Daniela Kerssen, Eva Hambruch, Wibke Klaas et al. · Journal of Biological Chemistry · 2006 · 110 citations · Full text

, , +15

Synthetic Farnesoid X Receptor Agonists Induce High-Density Lipoprotein-Mediated Transhepatic Cholesterol Efflux in Mice and Monkeys and Prevent Atherosclerosis in Cholesteryl Ester Transfer Protein Transgenic Low-Density Lipoprotein Receptor (−/−) Mice

Eva Hambruch, Shinobu Miyazaki‐Anzai, Ulrike K. Hahn et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 99 citations · Full text

, , +15

A Novel Pex14 Protein-interacting Site of Human Pex5 Is Critical for Matrix Protein Import into Peroxisomes

Alexander Neuhaus, Hamed Kooshapur, Janina Wolf et al. · Journal of Biological Chemistry · 2014 · 69 citations · Full text

, , +15

The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model

Philipp Schwabl, Eva Hambruch, Grant R. Budas et al. · Biomedicines · 2021 · 69 citations · Full text

, , +17

1–5 of 11